Company: Radicle Science, San Diego, CA
Company Description: Radicle Science has democratized clinical trials to conduct medical research at unprecedented cost, speed, scale and diversity. Through our Proof-as-a-Service, non-pharmaceuticals can easily access clinical trials for the first time in history. Since launching in 2021, we have already studied over 20,000 diverse Americans in some of history's largest or first rigorous trials on natural products.
Nomination Category: New Product & Service Categories
Nomination Sub Category: Health & Pharmaceuticals - Service
 Nomination Title: Radicle Science's Proof-as-a-Service
- Which will you submit for your nomination in this category, a video of up to five (5) minutes in length about the nominated new or new-version product or service, OR written answers to the questions for this category? (Choose one):
Written answers to the questions
- If you are submitting a video of up to five (5) minutes in length, provide the URL of the nominated video here, OR attach it to your entry via the "Add Attachments, Videos, or Links to This Entry" link above, through which you may also upload a copy of your video.
- If you are providing written answers for your submission, you must provide an answer to this first question: If this is a brand-new product, state the date on which it was released. If this is a new version of an existing product, state the date on which the update was released:
April 14, 2021
- If you are providing written answers for your submission, you must provide an answer to this second question: Describe the features, functions, and benefits of the nominated product or service (up to 350 words):
Total 325 words used.
Radicle Science is history’s first Proof-as-a-Service company. We have democratized clinical trials to conduct medical research with unprecedented:
- AFFORDABILITY: Our gold standard, double-blinded, randomized, placebo-controlled trials are 10x more affordable than traditional trials.
- SPEED: Our standardized study protocol delivers results in <180 days, rather than years.
- SCALE + DIVERSITY: We study hundreds of participants per trial, with intentional inclusion of women, minorities, and rural populations who have historically been excluded from medical research. This diversity is a stark contrast to traditional trials, which typically study a few dozen caucasian males in metro areas.
- OBJECTIVITY: Our standardized studies allow for truly objective, unbiased research. Traditional trials are custom designed for the study hypothesis, which increases the risk for bias error. Our standardization generates the most objective evidence.
For the first time in history, non-pharmaceuticals can easily access clinical trials for the first time in history. Our innovative model generates clinical proof that helps brands:
- Launch new products based on clinical data, not just ingredient studies or anecdotes
- Comply with the newest FTC guidelines on all health claims being backed by representative, randomized controlled trials
- Drive revenue with strong structure/function claims
- Build brand credibility & differentiation
- Make smarter business decisions
- Gain deep consumer and condition insights for targeted marketing
Radicle Science exists at the perfect intersection of science and technology to establish a new paradigm where:
- Companies formulate innovative products based on real evidence.
- Retailers carry products that they confidently know will work for their specific shoppers
- Consumers confidently buy proven products that work for someone like them.
- Healthcare providers finally trust and recommend non-pharmaceutical products
- Clinical trials are diverse, making the findings relevant to each of us, which improves personalized medicine and health equity.
- Insurance companies can finally reimburse for non-pharmaceuticals because they have proof of effectiveness and can lower their drug spending
Leveraging AI-driven, crowdsourced, virtual, direct-to-consumer, automated, standardized clinical trials, Radicle Science delivers much-needed clinical evidence to transform non-pharmaceutical products into precision health solutions.
- If you are providing written answers for your submission, you must provide an answer to this third question: Outline the market performance, critical reception, and customer satisfaction with the product or service to date. State monetary or unit sales figures to date, if possible, and how they compare to expectations or past performance. Provide links to laudatory product or service reviews. Include some customer testimonials, if applicable (up to 350 words):
Total 351 words used. If the word count is more than 25 words over the limit, please deduct one (1) point from your score.
Since launching in 2021, we have studied 20,000+ Americans in IRB-approved clinical trials across diverse populations and health conditions. We have conducted history's first large-scale, blinded, placebo-controlled clinical trials on a variety of natural ingredients, including the largest study on CBD in history.
In our first year of operations, we generated seven figures in revenue. In 2022, we grew 85% YoY. Our clients range from innovative startups to global CPG companies with market caps of $100B.
In addition to having objective clinical evidence to help formulate the best products for consumers, our clients have experienced many success stories, including:
- One client leveraged the effectiveness data from their Radicle study to become one of the few supplement brands chosen by Major League Baseball as an official sponsor.
- A client experienced a 188% increase in sales in the week following their announcement of their study results
- A publicly-traded brand saw an 11% jump in their stock price the day they announced their Radicle study results, andthis NASDAQ article attributed the gain to their research findings
- The positive study results of one client attracted the attention of Brooke Shields, who now serves as their Chief Brand Officer
“That's why we collaborated with the renowned medical experts and data scientists at Radicle Science to better understand CBD's potential as an ingredient and, in particular, its effect on women, an often-underrepresented population in health research studies." -Angie Tebbe, Rae Wellness' Cofounder and CEO
"...collaborating with industry-changing companies like Radicle Science who share our high standards. We are excited to partner with them to conduct novel large scale, randomized, placebo-controlled clinical trials to build our body of evidence to further validate the efficacy of our formulations." -Dr. Jeremy Stewart, Gaia Herb's Chief Scientist and VP of Scientific Affairs:
"We are dedicated to research and development, including choosing our ingredients using the best data available. We are thrilled to take our research to the next level with Radicle Science's disruptive clinical trials, which will provide invaluable data on optimal dosages and efficacy across all key demographics." James Schmachtenberger, Neurohacker’s Cofounder and CEO
- You have the option to answer this final question: Reference any attachments of supporting materials throughout this nomination and how they provide evidence of the claims you have made in this nomination (up to 250 words):
Total 248 words used.
"Radicle is generating some of history’s first data on the safety and effectiveness of non-prescription products used by millions; their findings will empower both consumers and health professionals to make better evidence-based health decisions." -Dr. Jonathan Fielding (Jonathan Fielding School of Public Health at UCLA, White House advisor)
“Radicle’s audacious mission has the potential to democratize clinical trials and unlock a future of abundant health products for all.” -Dr. Peter Diamandis (Chairman, XPrize, Fortune Magazine’s “World’s 50 Greatest Leaders”)
“...I believe Radicle has turned the traditional clinical model on its head. The Proof-as-a-Service model is a robust and disruptive way to communicate product effectiveness to consumers. Radicle Science is pioneering this next frontier of supplement credibility." Tom Aarts (Co-founder and Chairman of the Editorial Advisory Board of the Nutrition Business Journal, the industry's business journal of record.)
Radicle Science's innovative clinical research approach has garnered awards including:
- KPMG Top 10 US "Tech Innovator"
- UCSF Digital Health Awards "Rising Star" finalist in Consumer Wellness
- Named "2022 Cool Company" at the City of San Diego's Innovation Day
- Selected as the Industry Partner for two University of California San Diego "Innovation Sprints" in technology and marketing
- Chief Research Officer Dr. Emily Pauli named "Woman of the Year in Healthcare" by Stevie Awards and the Outstanding Leadership Award by Health 2.0
- Cofounder and Exeuctive Chairwoman Pelin Thorogood named "Maverick of the Year" by Stevie Awards and "Top 50 Leader in Life Science" by San Diego Business Journal
| Attachments/Videos/Links: |
|---|
|
